NCT00207142 - Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study) | Biotech Hunter

Enrollment

252

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

January 31, 2008

Conditions

HIV Infections

Interventions

DRUG

Atazanavir + 2 NRTIs

Capsules, tablets, Oral, 48 weeks (after a 26-to-30-week induction phase with ATV 300 mg + RTV 100 mg + 2 NRTIs)

DRUG

Atazanavir + Ritonavir + 2 NRTIs

Capsules, tablets, Oral, 48 weeks (after a 26-to-30-week induction phase with ATV 300 mg + RTV 100 mg + 2 NRTIs)

Trial Locations (27)

Local Institution, Tallinn

Local Institution, Le Kremlin-Bicêtre

Local Institution, Orléans

Local Institution, Paris

Local Institution, Suresnes

Local Institution, Düsseldorf

Local Institution, Hanover

Local Institution, Stuttgart

Local Institution, Ulm

Local Institution, Dublin

Local Institution, Brescia

Local Institution, Milan

Local Institution, Napoli

Local Institution, Padua

Local Institution, Riga

Local Institution, Cascais

Local Institution, Porto

Local Institution, Moscow

Local Institution, Saint Petersburg

Local Institution, Smolensk

Local Institution, Elche

Local Institution, Barcelona

Local Institution, Madrid

Local Institution, Valencia

Local Institution, Bristol

Local Institution, Edinburgh

Local Institution, London